Medicare Part D, the outpatient prescription drug benefit for Medicare beneficiaries, provides coverage above a catastrophic threshold for high out-of-pocket drug costs, but there is no cap on total out-of-pocket drug costs that beneficiaries pay each year. Recent legislative proposals would add a cap on out-of-pocket spending under Part D. This analysis focuses on the potential impact of different out-of-pocket spending caps in terms of how many beneficiaries would be affected and how much they could save.
Federal Register :: Medicare Program; Contract Year 2023 Policy
Pocket Drugs 2021
Stakeholder perspectives on the transformative IRA Part D benefit
Biden Unveils Plan for Medicare Funding in $6.8 Trillion Budget
Explaining the Prescription Drug Provisions in the Inflation
Drug pricing & price negotiations with Part D updates
As Congress Weighs Legislation, New Report Examines How Caps on Part D Spending Would Affect People with Medicare - Medicare Rights Center
CMS Releases 2024 Projected Medicare Part D Premium and Bid
Federal Register :: Medicare and Medicaid Programs; Contract Year